| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8236838 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 9 Pages |
Abstract
A role for low-dose DAC with or without HDAC-Is as radiosensitizers in HNSCC seems promising and is supportive of future clinical use, especially for combinations of DAC with LBH589 or MGCD0103, although the mechanisms by which they work will require further study.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Harlinde M.D., Marlies M.Sc., Sofie M.Sc., Sandra M.D., Ph.D.,